Mehta R, Billings LK, Liebl A, Vilsboll T, et al. Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes. Diabet Med 2022 Jun 16:e14901. doi: 10.1111/dme.14901.
PMID: 35708737